Re­silience notch­es $410M in fed­er­al fi­nanc­ing to bol­ster pro­duc­tion

Bio­phar­ma man­u­fac­tur­er Re­silience has net­ted a ma­jor in­vest­ment from the US De­part­ment of De­fense.

Re­silience inked a fi­nanc­ing agree­ment for a $410 mil­lion long-term loan from the DOD, work­ing with the US In­ter­na­tion­al De­vel­op­ment Fi­nance Cor­po­ra­tion. The loan will be used to bol­ster Re­silience’s do­mes­tic bio­man­u­fac­tur­ing ca­pac­i­ty and ca­pa­bil­i­ties for sev­er­al prod­ucts, ac­cord­ing to a press re­lease. This in­cludes bi­o­log­ics such as an­ti­bod­ies, pro­teins, vac­cines and mR­NA prod­ucts.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN